⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXAS News
Exact Sciences Corp
Healthcare Quarterly M&A Volume Decreases in Q4:25, According to Acquisition Data from LevinPro HC
globenewswire.com
ABT
EXAS
Genomic Testing Market Projected to Reach US$ 41.34 Billion by 2035, Supported by Rising Clinical Oncology Testing Volumes | Astute Analytica
globenewswire.com
NTRA
GH
EXAS
ILMN
PACB
TXG
TMO
TWST
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
globenewswire.com
MDXH
EXAS
Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt USA - Deutsch USA - Français USA - English APAC - English USA - English USA - čeština
prnewswire.com
AMGN
ILMN
VRTX
RIVN
TROW
PRGS
ALNY
REGN
GILD
BMY
MRK
ABBV
AZN
SNY
NVS
XRAY
EVTC
MYGN
RVTY
VTRS
BIIB
MDLZ
PFE
SNDX
EXAS
CRSP
NTRA
ON
IDXX
MDT
SYK
ISRG
DXCM
COO
AMZN
GOOG
MSFT
NVDA
IBM
INTC
QCOM
AMD
MU
ADBE
CRM
ORCL
SAP
CSCO
ACN
HPQ
DELL
MSCI
FIS
PAYX
ADP
BBBY
ROST
TJX
MCHP
NXPI
SNPS
CDNS
WDC
STX
KLAC
LRCX
AMAT
CTAS
PAYC
NOW
DDOG
ZS
PANW
FTNT
SNOW
PYPL
V
MA
AXP
BAC
JPM
WFC
C
GS
MS
SCHW
ELAN
ZTS
ALGN
XOM
CVX
KO
PEP
MCD
DIS
CMCSA
VZ
T
NFLX
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
globenewswire.com
EXAS
FRGE
TBHC
FFWM
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—FFWM, EXAS, TBHC, and FRGE
globenewswire.com
FFWM
EXAS
TBHC
FRGE
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
businesswire.com
QTRX
ILMN
EXAS
DGX
PFE
ARVN
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
FRGE
EXAS
CIVI
KVUE
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
globenewswire.com
GILD
EXAS
RLMD
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX